Dr. Leo James and team propose in @MolecularCell that TRIM21 evolved through competition with pathogens to induce #autophagy of diverse and complex substrates, potentially explaining its versatility for targeted protein degradation.
https://t.co/sDiEteEe8H
Rapid Affinity Characterization of Cell-Free Expressed Nanobodies Directly in Lysate with Biolayer Interferometry via Antigen-Immobilized Biosensors
https://t.co/NOQSEXfi2C
Infection of rhesus macaques with a chimeric virus uncovers a recipe for broadly neutralizing anti-HIV antibodies @ScienceMagazine
https://t.co/K1I50yK6DX
https://t.co/AbboXfR6nn
Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease | New England Journal of Medicine https://t.co/JnXJRVlbzr
Maybe one of the most important IBD papers - 3-5% of CD disease caused by IL10 autoantibodies... B-cell therapies???
A whole genome sequencing assay named HPV-DeepSeek sniffs out signs of residual disease after surgery in patients with #HPV+ head and neck cancer, and detects recurrence earlier than digital PCR and standard clinical criteria. @FadenLab@BIDharvardOHNS https://t.co/bGrJhklXrP
A landmark study shows that latent #HIV can convert CD4+ T cells to CD8+ T cells and identifies the latter as a previously overlooked component of the viral reservoir—a surprising finding with critical implications for HIV cure efforts. @sysu_1924 https://t.co/y5F63thTkm
In the last year, we’ve:
✅Developed a next-generation in vivo CAR-T platform of high specificity & efficacy
✅Entered the second half of recruitment in our first in-human clinical trial, CARxALL
✅Built and strengthened collaborations with research institutions & global partners
Wow just heard about new clinical trials of a new drug for hep B infection at the European HIV hepatitis meeting - antisense oligo nucleotides showing promising results in those already taking nucleotide/side inhibitors. And for hep D a new entry inhibitor.@hkjcghi@MedCambridge
1/ Congratulations to our UK colleagues on this landmark @NEJM study: “Interleukin 10 Autoantibodies and HLA DRB1*01:03 in IBD”https://t.co/8i85vCK9ka
A powerful example of how discoveries from rare monogenic #VEOIBD can illuminate mechanisms relevant to common #IBD.
I am super proud to post a BEAUTIFUL review in Nature Reviews Microbiology that started as Dinh's PhD thesis introduction, and matured over a two year period, into a view on how he studies RNA virus evolution and how those concepts can be used in applied virology. Dinh Tran joined my group as a PhD student coming from a background of solid evolutionary sciences and population genetics, and trying to transform his wisdom to us and how we develop antiviral approaches. He is now a postdoctoral fellow, applying all these concepts to his own research program.
This is a very useful review, I hope you enjoy it. It is written for a broad audience, for students and scientists in the field and in related fields.
https://t.co/DyxiUyW3Rt
Share it with everyone!
Today my laboratory is thrilled to announce a major breakthrough in the fight against the common cold and other diseases like hand,foot, and mouth disease acute flaccid myelitis caused by picornaviruses. We present the first structure of picornaviral 2C, bound to ssRNA (1/n)
Interactome mapping has been stuck at a few hundred baits over months. HIP-MS changes the regime: ~10,000 pulldowns/week at 500 samples/day, fully automated. A new era for interactomics — and a precursor to high-throughput proteomics writ large. https://t.co/Fozb4LfdQk
📝 A new @MolecularCell study led by Dr. Leo James demonstrate that TRIM21 rapidly intercepts antibody-pathogen complexes, leading to ubiquitin ligase activation. https://t.co/OtuYNFwY2Q
They propose that TRIM21 evolved through competition with pathogens to induce autophagy of diverse and complex substrates. 🦠
#OpenAccess
Can AI predict which flu strains will jump to humans? New preprint uses protein language models to forecast influenza host tropism & zoonotic risk, across 9 animal families.
No subtype assumptions.
Full proteome.
90%+ accuracy.
A step toward proactive pandemic prevention.
1/5
Cell identity is written in the proteome, not in the DNA, and not always in the RNA. Out on bioRxiv today: The first cell type-resolved, MS-based proteomic atlas of the human body.
https://t.co/5RJ0nVoQ81